Cases & Deals

TxCell completes €8 million private placement of new shares

Clients TxCell SA

Jones Day advised TxCell SA, a biotech company specializing in innovative, personalized cell-based immunotherapies, as well as Bryan, Garnier & Co. as global coordinator and bookrunner, in connection with its €8 million (US$9 million) private placement of new shares to institutional investors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.